SlideShare a Scribd company logo
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 1
A seminar as a part of curricular requirement
for I year M. Pharm I semester
Presented by
A. Harsha Vardan Naidu (20L81S0107)
M. Pharmacy
Department of Pharmacology
Under the guidance of
Mr. A. Sudheer kumar, M. Pharm.
Associate Professor, Department of Pharmacology.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 2
• Introduction to Epilepsy
• Types of Seizures
• Classification
• Mechanism of Action
• Pharmacokinetics
• Uses
• Adverse Effects
• Contraindications
• New Drugs
• References
Contents
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 3
• Convulsion is a condition in which muscles contract and relax quickly
and cause uncontrolled shaking of the body.
• Seizure is a change in electrical activity between neurons that causes
temporary abnormalities in muscle tone or movements (stiffness,
twitching), behaviours, sensations or states of awareness.
• Epilepsy is a neurological disorder in which brain activity becomes
abnormal, causing seizures or periods of unusual behaviour, sensations,
and sometimes loss of awareness.
• A seizure is a single occurrence, whereas epilepsy is a neurological
condition characterized by two or more unprovoked seizures.
Introduction
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 4
• Brain conditions including stroke or a tumour
• Genetical problem
• Head trauma, from a vehicle accident
• Drug abuse or alcohol misuse
• Infectious diseases like viral encephalitis
• Lack of oxygen during birth
• Prenatal injury- brain damage that occurs before child birth
• COVID-19 infection
• Blood vessel malformations
Causes of Epilepsy:
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 5
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 6
Stages of seizures
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 7
• Partial seizures - Simple partial seizure
- Complex partial seizure
- Partial with secondarily generalised seizure
• Generalized seizures - Tonic clonic/ grandmal seizure
- Clonic seizure
- Tonic seizure
- Atonic seizure
- Myoclonic seizure
- Absence/ Petit mal seizure
• Non epileptic seizure- not related to epilepsy, occurs due to diabetes/ high fever.
• Status epilepticus- condition where seizure lasts for more than 5 mins.
Types of seizures
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 8
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 9
Managing seizures
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 10
1. Hydantoins: Phenytoin, Mephentoin
2. Barbiturates: Phenobarbitone, Mephobarbitone
3. Deoxy barbiturate: Primidone
4. Benzodiazepines: Diazepam, Clonazepam, Lorazepam
5. Iminostilbenes: Carbamazepine
6. Succinimides: Ethosuximide
7. GABA transaminase inhibitors: Valproic acid, Vigabatrin
8. GABA analogs: Gabapentin, Pregabalin
9. Others: Lamotrigine, Levetiracetam
Classification
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 11
Conduction of nerve impulse
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 12
Mechanism of action
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 13
Phenytoin
• First line drug for partial seizures.
• Inhibits Na+ channels.
• Prodrug- Fosphenytoin for IM/IV administration. High plasma
protein binding.
• Adverse effects: CNS sedation ( drowsiness, ataxia, confusion,
insomnia, nystagmus), gum hyperplasia, hirsutism.
Carbamazepine
• First line drug for partial seizures.
• Inhibits Na+ channels.
• Adverse effects- CNS sedation, agranulocytosis and aplastic anaemia
in elderly patients, leukopenia.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 14
Phenobarbital
• Used for partial seizures, effective in neonates.
• Second line drug in adults due to severe CNS sedation.
• Allosteric modulator of GABA-A receptor (increase open time).
• Adverse effects- CNS sedation but produces excitation in some
patients. Skin rashes if allergic. Tolerance and dependence may be
possible.
Primidone
• Used for partial seizures.
• Allosteric modulator of GABA-A receptor (increase open time).
• Not highly bound to plasma.
• Adverse effects- CNS sedation.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 15
Benzodiazepines
• Eg- Diazepam, Clonazepam.
• Used to treat status epilepticus.
• Allosteric modulators of GABA-A receptor- increase frequency.
• Adverse effects- CNS sedation, paradoxical hyper excitability in
children, tolerance and dependence.
Valproate
• Used for partial seizures, first line drug for generalized seizures.
• Enhance GABA transmission, block Na+ channels, activates K+
channels.
• Adverse effects- CNS depression, anorexia, nausea, vomiting, hair
loss, weight gain, may cause birth defects.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 16
Ethosuximide
• Used for absence seizures.
• Blocks T-type Ca++ currents in thalamus.
• Adverese effects- gastric distress, pain, nausea, vomiting.
• Less CNS side effects than other anti-epileptic drugs, transient
fatigue, dizziness, headache.
Oxcarbamazepine
• Approved for add-on therapy, monotherapy for partial seizures, that
are refractory to other antiepileptic drugs.
• Activity dependent blockade of Na+ channels, also open K+
channels.
• Similar to carbamazepine, it causes CNS sedation, but may be less
toxic.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 17
Gabapentin
• Add-on therapy for partial seizures.
• Also effective as monotherapy.
• Interfere with GABA uptake.
• Adverse effects- less CNS sedative than other classic anti-epileptic
drugs.
Lamotrigine
• Add-on therapy and monotherapy for refractive partial seizures.
• Effective against generalized seizures.
• Inhibition of Na+ channels, inhibition of glutamate release, may
inhibit Ca++ channels.
• Less CNS sedative than other anti-epileptic drugs, dermatitis.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 18
Tiagabine
• Add- on therapy for partial seizures.
• Interferes with GABA reuptake.
• CNS sedative
• Minimal drug interaction.
Zonisamide
• Add- on therapy for partial and generalized seizures.
• Blocks Na+ channels and T- type Ca++ channels.
• Causes CNS sedation.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 19
Felbamate
• Third-line drug for refractory partial seizures.
• Frequency dependent- inhibition of Na+ channels, modulation of
NMDA receptors.
• Aplastic anaemia and severe hepatits reduces its use.
Levetiracitam
• Add- on therapy for partial seizures.
• Binds to synaptical vessicle protein SV2A, may regulate
neurotransmitter release.
• Causes CNS ddepression.
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 20
• Good absorption from gut, with a bioavailability of 80- 100%.
• They show minimal plasma protein binding( except phenytoin,
valproic acid).
• Half life is usually 12- 24 hours and it increases upto 60 hours
when plasma concentration of drug increases.
• Metabolised in liver by non-CYP450 isoenzymes.
• Enzyme inducers- Phenytoin, Phenobarbital.
• Enzyme inhibitors- Valproate, Topiramate.
• Primarily cleared renally.
Pharmacokinetic profile
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 21
• Used to treat partial, generalized and mixed seizures.
• Used to treat Status epilepticus
• Used as prophylaxis in case of tumours in brain.
• Manic depressive illness and acute mania
• Phenytoin is a group 1B anti-arrhythmic agent.
• Several drugs, especially carbamazepine and lamotrigine, are
useful for bipolar disorder.
• Many drugs are useful in migraine, e.g., phenytoin, gabapentin,
topiramate.
Uses of Antiepileptic Drugs
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 22
• Hypersensitivity reactions like rashes, photosensitivity, hepatitis
• Vomiting, diarrhoea, weight loss, tremors
• At high plasma levels- ataxia, vertigo, nystagmus, drowsiness
• Gum hypertrophy
• Aplastic anaemia
• Foetal hydantoin syndrome
• Osteoporosis
• Teratogenesis
• Neuropathy, coma
• Epigastric pain, hypotension, arrythmias
Adverse effects
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 23
Contraindications
• Cardiac patients
• Pregnant women
• Patients with livers disorder
• People with lung infections etc
Latest discovery
• Levitiracitam
• Brivaracetam
• Cannabidiol
• Stiripentol
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 24
1. Padmaja Udaykumar. Pharmacology for Dental and Allied Health
Sciences. 2017; 4th edition.
2. Tripathi, K. D. Essentials of Medical Pharmacology. 2013. JP
Medical Ltd.
3. Christopher Melinosky. Epilepsy drugs used to treat seizures.
WebMD. 2020.
4. Marketa Mavanova. Pharmacokinetic characteristics of
antiepileptic drugs. NCBI. 2016; 6(1): 8-20.
References
RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 25
THANK YOU

More Related Content

What's hot

Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
Kalaivanisathishr
 
Cholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugsCholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugs
Sri Ramachandra Medical college and Research Institute
 
Ganglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffiGanglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffi
Dr.UMER SUFYAN M
 
Skeletal muscle relaxant
Skeletal muscle relaxantSkeletal muscle relaxant
Skeletal muscle relaxant
Subramani Parasuraman
 
Anti convulsants
Anti convulsantsAnti convulsants
Anti convulsants
Neha Kumari
 
Anticonvulsants
AnticonvulsantsAnticonvulsants
Anticonvulsants
Tandzile Simelane
 
pharmacology of myasthenia gravis
pharmacology of myasthenia gravispharmacology of myasthenia gravis
pharmacology of myasthenia gravis
Koppala RVS Chaitanya
 
general and local anesthesia
general and local anesthesia general and local anesthesia
general and local anesthesia
SONALPANDE5
 
Benzodiazepines drm
Benzodiazepines drmBenzodiazepines drm
Benzodiazepines drm
Dhanashri Mali
 
cholinergic receptors
cholinergic receptorscholinergic receptors
cholinergic receptors
Mohamed Kanfoud
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
Dr. Mohit Kulmi
 
Antiepileptics (New) - drdhriti
Antiepileptics (New) - drdhritiAntiepileptics (New) - drdhriti
Antiepileptics (New) - drdhriti
http://neigrihms.gov.in/
 
Drugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucomaDrugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucoma
AshviniGovande
 
Anti parkinsonian drug ppt
Anti parkinsonian drug pptAnti parkinsonian drug ppt
Anti parkinsonian drug ppt
HIMANSHUKUMAR822
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Kameshwaran Sugavanam
 
H1 & H2 receptor antagonist
H1 & H2 receptor antagonistH1 & H2 receptor antagonist
H1 & H2 receptor antagonist
Ashok Jangra
 
SAR of Anticonvulsant Drugs
SAR of Anticonvulsant DrugsSAR of Anticonvulsant Drugs
SAR of Anticonvulsant Drugs
Chhabi Acharya
 
Drugs used in Parkinsons Disease ( anti- Parkinson drugs)
Drugs used in Parkinsons Disease ( anti- Parkinson drugs) Drugs used in Parkinsons Disease ( anti- Parkinson drugs)
Drugs used in Parkinsons Disease ( anti- Parkinson drugs)
Ravish Yadav
 
antiepileptic drugs classification
antiepileptic drugs classification antiepileptic drugs classification
Sympathomimetic
SympathomimeticSympathomimetic
Sympathomimetic
Viraj Shinde
 

What's hot (20)

Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Cholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugsCholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugs
 
Ganglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffiGanglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffi
 
Skeletal muscle relaxant
Skeletal muscle relaxantSkeletal muscle relaxant
Skeletal muscle relaxant
 
Anti convulsants
Anti convulsantsAnti convulsants
Anti convulsants
 
Anticonvulsants
AnticonvulsantsAnticonvulsants
Anticonvulsants
 
pharmacology of myasthenia gravis
pharmacology of myasthenia gravispharmacology of myasthenia gravis
pharmacology of myasthenia gravis
 
general and local anesthesia
general and local anesthesia general and local anesthesia
general and local anesthesia
 
Benzodiazepines drm
Benzodiazepines drmBenzodiazepines drm
Benzodiazepines drm
 
cholinergic receptors
cholinergic receptorscholinergic receptors
cholinergic receptors
 
Anti parkinsonian drugs
Anti parkinsonian drugsAnti parkinsonian drugs
Anti parkinsonian drugs
 
Antiepileptics (New) - drdhriti
Antiepileptics (New) - drdhritiAntiepileptics (New) - drdhriti
Antiepileptics (New) - drdhriti
 
Drugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucomaDrugs used in myasthenia gravis and galucoma
Drugs used in myasthenia gravis and galucoma
 
Anti parkinsonian drug ppt
Anti parkinsonian drug pptAnti parkinsonian drug ppt
Anti parkinsonian drug ppt
 
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's DiseaseAnti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
Anti-Parkinsonism Drugs / Drugs Used in the treatment of Parkinson's Disease
 
H1 & H2 receptor antagonist
H1 & H2 receptor antagonistH1 & H2 receptor antagonist
H1 & H2 receptor antagonist
 
SAR of Anticonvulsant Drugs
SAR of Anticonvulsant DrugsSAR of Anticonvulsant Drugs
SAR of Anticonvulsant Drugs
 
Drugs used in Parkinsons Disease ( anti- Parkinson drugs)
Drugs used in Parkinsons Disease ( anti- Parkinson drugs) Drugs used in Parkinsons Disease ( anti- Parkinson drugs)
Drugs used in Parkinsons Disease ( anti- Parkinson drugs)
 
antiepileptic drugs classification
antiepileptic drugs classification antiepileptic drugs classification
antiepileptic drugs classification
 
Sympathomimetic
SympathomimeticSympathomimetic
Sympathomimetic
 

Similar to An Overview on Anti-epileptic Drugs

Pharmacology of Anti-depressants
Pharmacology of Anti-depressantsPharmacology of Anti-depressants
General Anaesthetics
General AnaestheticsGeneral Anaesthetics
HISTAMINE AND ANTIHISTAMINE
HISTAMINE AND ANTIHISTAMINE HISTAMINE AND ANTIHISTAMINE
Immunotherapeutics
ImmunotherapeuticsImmunotherapeutics
HYPERTENSION
HYPERTENSIONHYPERTENSION
Anticoagulants
AnticoagulantsAnticoagulants
NEURO DEGENERATIVE DISEASES
NEURO DEGENERATIVE DISEASESNEURO DEGENERATIVE DISEASES
Serotonin
SerotoninSerotonin
Microbial Assay Of Vitamin of B Series
Microbial Assay Of Vitamin of B SeriesMicrobial Assay Of Vitamin of B Series
Screening models of Anti diabetics.
Screening models of Anti diabetics.Screening models of Anti diabetics.
DRUGS USED IN HEART FAILURE
DRUGS USED IN HEART FAILUREDRUGS USED IN HEART FAILURE
An Overview of Antipsychotic Drugs
An Overview of Antipsychotic DrugsAn Overview of Antipsychotic Drugs
Sedative-Hypnotics Drugs
Sedative-Hypnotics Drugs Sedative-Hypnotics Drugs
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
Raghavendra institute of pharmaceutical education and research .
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Target Validation
Target ValidationTarget Validation
GENETIC VARIATION IN GPCR
GENETIC VARIATION IN GPCRGENETIC VARIATION IN GPCR
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’SSEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Raghavendra institute of pharmaceutical education and research .
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsScreening Models Of Anti Cancer Drugs

Similar to An Overview on Anti-epileptic Drugs (20)

Pharmacology of Anti-depressants
Pharmacology of Anti-depressantsPharmacology of Anti-depressants
Pharmacology of Anti-depressants
 
General Anaesthetics
General AnaestheticsGeneral Anaesthetics
General Anaesthetics
 
HISTAMINE AND ANTIHISTAMINE
HISTAMINE AND ANTIHISTAMINE HISTAMINE AND ANTIHISTAMINE
HISTAMINE AND ANTIHISTAMINE
 
Immunotherapeutics
ImmunotherapeuticsImmunotherapeutics
Immunotherapeutics
 
HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSION
 
Anticoagulants
AnticoagulantsAnticoagulants
Anticoagulants
 
NEURO DEGENERATIVE DISEASES
NEURO DEGENERATIVE DISEASESNEURO DEGENERATIVE DISEASES
NEURO DEGENERATIVE DISEASES
 
Serotonin
SerotoninSerotonin
Serotonin
 
Microbial Assay Of Vitamin of B Series
Microbial Assay Of Vitamin of B SeriesMicrobial Assay Of Vitamin of B Series
Microbial Assay Of Vitamin of B Series
 
Screening models of Anti diabetics.
Screening models of Anti diabetics.Screening models of Anti diabetics.
Screening models of Anti diabetics.
 
DRUGS USED IN HEART FAILURE
DRUGS USED IN HEART FAILUREDRUGS USED IN HEART FAILURE
DRUGS USED IN HEART FAILURE
 
An Overview of Antipsychotic Drugs
An Overview of Antipsychotic DrugsAn Overview of Antipsychotic Drugs
An Overview of Antipsychotic Drugs
 
Sedative-Hypnotics Drugs
Sedative-Hypnotics Drugs Sedative-Hypnotics Drugs
Sedative-Hypnotics Drugs
 
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
Target Validation
Target ValidationTarget Validation
Target Validation
 
GENETIC VARIATION IN GPCR
GENETIC VARIATION IN GPCRGENETIC VARIATION IN GPCR
GENETIC VARIATION IN GPCR
 
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’SSEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIES
 
Screening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer DrugsScreening Models Of Anti Cancer Drugs
Screening Models Of Anti Cancer Drugs
 

More from Raghavendra institute of pharmaceutical education and research .

JOURNAL CLUB PRESENTATION (20L81S0710-PA)
JOURNAL CLUB PRESENTATION (20L81S0710-PA)JOURNAL CLUB PRESENTATION (20L81S0710-PA)
JOURNAL CLUB PRESENTATION (20L81S0710-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0714-PA )
JOURNAL CLUB PRESENTATION (20L81S0714-PA )JOURNAL CLUB PRESENTATION (20L81S0714-PA )
JOURNAL CLUB PRESENTATION (20L81S0714-PA )
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0706-PA)
JOURNAL CLUB PRESENTATION (20L81S0706-PA)JOURNAL CLUB PRESENTATION (20L81S0706-PA)
JOURNAL CLUB PRESENTATION (20L81S0706-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0712-PA)
JOURNAL CLUB PRESENTATION (20L81S0712-PA)JOURNAL CLUB PRESENTATION (20L81S0712-PA)
JOURNAL CLUB PRESENTATION (20L81S0712-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0713-PA)
JOURNAL CLUB PRESENTATION (20L81S0713-PA)JOURNAL CLUB PRESENTATION (20L81S0713-PA)
JOURNAL CLUB PRESENTATION (20L81S0713-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0707-PA)
JOURNAL CLUB PRESENTATION (20L81S0707-PA)JOURNAL CLUB PRESENTATION (20L81S0707-PA)
JOURNAL CLUB PRESENTATION (20L81S0707-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0702-PA)
JOURNAL CLUB PRESENTATION (20L81S0702-PA)JOURNAL CLUB PRESENTATION (20L81S0702-PA)
JOURNAL CLUB PRESENTATION (20L81S0702-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0705-PA)
JOURNAL CLUB PRESENTATION (20L81S0705-PA)JOURNAL CLUB PRESENTATION (20L81S0705-PA)
JOURNAL CLUB PRESENTATION (20L81S0705-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0703-PA)
JOURNAL CLUB PRESENTATION (20L81S0703-PA)JOURNAL CLUB PRESENTATION (20L81S0703-PA)
JOURNAL CLUB PRESENTATION (20L81S0703-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0701-PA)
JOURNAL CLUB PRESENTATION (20L81S0701-PA)JOURNAL CLUB PRESENTATION (20L81S0701-PA)
JOURNAL CLUB PRESENTATION (20L81S0701-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0709-PA)
JOURNAL CLUB PRESENTATION (20L81S0709-PA)JOURNAL CLUB PRESENTATION (20L81S0709-PA)
JOURNAL CLUB PRESENTATION (20L81S0709-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0711-PA)
JOURNAL CLUB PRESENTATION (20L81S0711-PA)JOURNAL CLUB PRESENTATION (20L81S0711-PA)
JOURNAL CLUB PRESENTATION (20L81S0711-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0704-PA )
JOURNAL CLUB PRESENTATION (20L81S0704-PA )JOURNAL CLUB PRESENTATION (20L81S0704-PA )
JOURNAL CLUB PRESENTATION (20L81S0704-PA )
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0708-PA)
JOURNAL CLUB PRESENTATION (20L81S0708-PA)JOURNAL CLUB PRESENTATION (20L81S0708-PA)
JOURNAL CLUB PRESENTATION (20L81S0708-PA)
Raghavendra institute of pharmaceutical education and research .
 
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
Raghavendra institute of pharmaceutical education and research .
 
Validation master plan
Validation master planValidation master plan
Physical Evaluation of Crude Drugs
Physical Evaluation of Crude Drugs Physical Evaluation of Crude Drugs
QUALIFICATION OF FT-IR
QUALIFICATION OF FT-IRQUALIFICATION OF FT-IR

More from Raghavendra institute of pharmaceutical education and research . (20)

JOURNAL CLUB PRESENTATION (20L81S0710-PA)
JOURNAL CLUB PRESENTATION (20L81S0710-PA)JOURNAL CLUB PRESENTATION (20L81S0710-PA)
JOURNAL CLUB PRESENTATION (20L81S0710-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0714-PA )
JOURNAL CLUB PRESENTATION (20L81S0714-PA )JOURNAL CLUB PRESENTATION (20L81S0714-PA )
JOURNAL CLUB PRESENTATION (20L81S0714-PA )
 
JOURNAL CLUB PRESENTATION (20L81S0706-PA)
JOURNAL CLUB PRESENTATION (20L81S0706-PA)JOURNAL CLUB PRESENTATION (20L81S0706-PA)
JOURNAL CLUB PRESENTATION (20L81S0706-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0712-PA)
JOURNAL CLUB PRESENTATION (20L81S0712-PA)JOURNAL CLUB PRESENTATION (20L81S0712-PA)
JOURNAL CLUB PRESENTATION (20L81S0712-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0713-PA)
JOURNAL CLUB PRESENTATION (20L81S0713-PA)JOURNAL CLUB PRESENTATION (20L81S0713-PA)
JOURNAL CLUB PRESENTATION (20L81S0713-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0707-PA)
JOURNAL CLUB PRESENTATION (20L81S0707-PA)JOURNAL CLUB PRESENTATION (20L81S0707-PA)
JOURNAL CLUB PRESENTATION (20L81S0707-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0702-PA)
JOURNAL CLUB PRESENTATION (20L81S0702-PA)JOURNAL CLUB PRESENTATION (20L81S0702-PA)
JOURNAL CLUB PRESENTATION (20L81S0702-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0705-PA)
JOURNAL CLUB PRESENTATION (20L81S0705-PA)JOURNAL CLUB PRESENTATION (20L81S0705-PA)
JOURNAL CLUB PRESENTATION (20L81S0705-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
 
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0401-PA & QA)
 
JOURNAL CLUB PRESENTATION (20L81S0703-PA)
JOURNAL CLUB PRESENTATION (20L81S0703-PA)JOURNAL CLUB PRESENTATION (20L81S0703-PA)
JOURNAL CLUB PRESENTATION (20L81S0703-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0701-PA)
JOURNAL CLUB PRESENTATION (20L81S0701-PA)JOURNAL CLUB PRESENTATION (20L81S0701-PA)
JOURNAL CLUB PRESENTATION (20L81S0701-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0709-PA)
JOURNAL CLUB PRESENTATION (20L81S0709-PA)JOURNAL CLUB PRESENTATION (20L81S0709-PA)
JOURNAL CLUB PRESENTATION (20L81S0709-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0711-PA)
JOURNAL CLUB PRESENTATION (20L81S0711-PA)JOURNAL CLUB PRESENTATION (20L81S0711-PA)
JOURNAL CLUB PRESENTATION (20L81S0711-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0704-PA )
JOURNAL CLUB PRESENTATION (20L81S0704-PA )JOURNAL CLUB PRESENTATION (20L81S0704-PA )
JOURNAL CLUB PRESENTATION (20L81S0704-PA )
 
JOURNAL CLUB PRESENTATION (20L81S0708-PA)
JOURNAL CLUB PRESENTATION (20L81S0708-PA)JOURNAL CLUB PRESENTATION (20L81S0708-PA)
JOURNAL CLUB PRESENTATION (20L81S0708-PA)
 
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
JOURNAL CLUB PRESENTATION (20L81S0403-PA & QA)
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
Physical Evaluation of Crude Drugs
Physical Evaluation of Crude Drugs Physical Evaluation of Crude Drugs
Physical Evaluation of Crude Drugs
 
QUALIFICATION OF FT-IR
QUALIFICATION OF FT-IRQUALIFICATION OF FT-IR
QUALIFICATION OF FT-IR
 

Recently uploaded

JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSJAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
Sérgio Sacani
 
Anti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark UniverseAnti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark Universe
Sérgio Sacani
 
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfMending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Selcen Ozturkcan
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
University of Maribor
 
AJAY KUMAR NIET GreNo Guava Project File.pdf
AJAY KUMAR NIET GreNo Guava Project File.pdfAJAY KUMAR NIET GreNo Guava Project File.pdf
AJAY KUMAR NIET GreNo Guava Project File.pdf
AJAY KUMAR
 
fermented food science of sauerkraut.pptx
fermented food science of sauerkraut.pptxfermented food science of sauerkraut.pptx
fermented food science of sauerkraut.pptx
ananya23nair
 
11.1 Role of physical biological in deterioration of grains.pdf
11.1 Role of physical biological in deterioration of grains.pdf11.1 Role of physical biological in deterioration of grains.pdf
11.1 Role of physical biological in deterioration of grains.pdf
PirithiRaju
 
Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)
Sciences of Europe
 
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Leonel Morgado
 
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
ABHISHEK SONI NIMT INSTITUTE OF MEDICAL AND PARAMEDCIAL SCIENCES , GOVT PG COLLEGE NOIDA
 
Direct Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart AgricultureDirect Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart Agriculture
International Food Policy Research Institute- South Asia Office
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
by6843629
 
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
Sérgio Sacani
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
vluwdy49
 
HOW DO ORGANISMS REPRODUCE?reproduction part 1
HOW DO ORGANISMS REPRODUCE?reproduction part 1HOW DO ORGANISMS REPRODUCE?reproduction part 1
HOW DO ORGANISMS REPRODUCE?reproduction part 1
Shashank Shekhar Pandey
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Sérgio Sacani
 
Tissue fluids_etiology_volume regulation_pressure.pptx
Tissue fluids_etiology_volume regulation_pressure.pptxTissue fluids_etiology_volume regulation_pressure.pptx
Tissue fluids_etiology_volume regulation_pressure.pptx
muralinath2
 
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
Advanced-Concepts-Team
 
Summary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdfSummary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdf
vadgavevedant86
 
HUMAN EYE By-R.M Class 10 phy best digital notes.pdf
HUMAN EYE By-R.M Class 10 phy best digital notes.pdfHUMAN EYE By-R.M Class 10 phy best digital notes.pdf
HUMAN EYE By-R.M Class 10 phy best digital notes.pdf
Ritik83251
 

Recently uploaded (20)

JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSJAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
 
Anti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark UniverseAnti-Universe And Emergent Gravity and the Dark Universe
Anti-Universe And Emergent Gravity and the Dark Universe
 
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfMending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
 
Randomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNERandomised Optimisation Algorithms in DAPHNE
Randomised Optimisation Algorithms in DAPHNE
 
AJAY KUMAR NIET GreNo Guava Project File.pdf
AJAY KUMAR NIET GreNo Guava Project File.pdfAJAY KUMAR NIET GreNo Guava Project File.pdf
AJAY KUMAR NIET GreNo Guava Project File.pdf
 
fermented food science of sauerkraut.pptx
fermented food science of sauerkraut.pptxfermented food science of sauerkraut.pptx
fermented food science of sauerkraut.pptx
 
11.1 Role of physical biological in deterioration of grains.pdf
11.1 Role of physical biological in deterioration of grains.pdf11.1 Role of physical biological in deterioration of grains.pdf
11.1 Role of physical biological in deterioration of grains.pdf
 
Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)
 
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
 
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
MICROBIAL INTERACTION PPT/ MICROBIAL INTERACTION AND THEIR TYPES // PLANT MIC...
 
Direct Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart AgricultureDirect Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart Agriculture
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
 
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...Discovery of An Apparent Red, High-Velocity Type Ia Supernova at  𝐳 = 2.9  wi...
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
 
HOW DO ORGANISMS REPRODUCE?reproduction part 1
HOW DO ORGANISMS REPRODUCE?reproduction part 1HOW DO ORGANISMS REPRODUCE?reproduction part 1
HOW DO ORGANISMS REPRODUCE?reproduction part 1
 
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defectsThe binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
 
Tissue fluids_etiology_volume regulation_pressure.pptx
Tissue fluids_etiology_volume regulation_pressure.pptxTissue fluids_etiology_volume regulation_pressure.pptx
Tissue fluids_etiology_volume regulation_pressure.pptx
 
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
 
Summary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdfSummary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdf
 
HUMAN EYE By-R.M Class 10 phy best digital notes.pdf
HUMAN EYE By-R.M Class 10 phy best digital notes.pdfHUMAN EYE By-R.M Class 10 phy best digital notes.pdf
HUMAN EYE By-R.M Class 10 phy best digital notes.pdf
 

An Overview on Anti-epileptic Drugs

  • 1. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 1 A seminar as a part of curricular requirement for I year M. Pharm I semester Presented by A. Harsha Vardan Naidu (20L81S0107) M. Pharmacy Department of Pharmacology Under the guidance of Mr. A. Sudheer kumar, M. Pharm. Associate Professor, Department of Pharmacology.
  • 2. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 2 • Introduction to Epilepsy • Types of Seizures • Classification • Mechanism of Action • Pharmacokinetics • Uses • Adverse Effects • Contraindications • New Drugs • References Contents
  • 3. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 3 • Convulsion is a condition in which muscles contract and relax quickly and cause uncontrolled shaking of the body. • Seizure is a change in electrical activity between neurons that causes temporary abnormalities in muscle tone or movements (stiffness, twitching), behaviours, sensations or states of awareness. • Epilepsy is a neurological disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behaviour, sensations, and sometimes loss of awareness. • A seizure is a single occurrence, whereas epilepsy is a neurological condition characterized by two or more unprovoked seizures. Introduction
  • 4. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 4 • Brain conditions including stroke or a tumour • Genetical problem • Head trauma, from a vehicle accident • Drug abuse or alcohol misuse • Infectious diseases like viral encephalitis • Lack of oxygen during birth • Prenatal injury- brain damage that occurs before child birth • COVID-19 infection • Blood vessel malformations Causes of Epilepsy:
  • 5. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 5
  • 6. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 6 Stages of seizures
  • 7. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 7 • Partial seizures - Simple partial seizure - Complex partial seizure - Partial with secondarily generalised seizure • Generalized seizures - Tonic clonic/ grandmal seizure - Clonic seizure - Tonic seizure - Atonic seizure - Myoclonic seizure - Absence/ Petit mal seizure • Non epileptic seizure- not related to epilepsy, occurs due to diabetes/ high fever. • Status epilepticus- condition where seizure lasts for more than 5 mins. Types of seizures
  • 8. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 8
  • 9. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 9 Managing seizures
  • 10. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 10 1. Hydantoins: Phenytoin, Mephentoin 2. Barbiturates: Phenobarbitone, Mephobarbitone 3. Deoxy barbiturate: Primidone 4. Benzodiazepines: Diazepam, Clonazepam, Lorazepam 5. Iminostilbenes: Carbamazepine 6. Succinimides: Ethosuximide 7. GABA transaminase inhibitors: Valproic acid, Vigabatrin 8. GABA analogs: Gabapentin, Pregabalin 9. Others: Lamotrigine, Levetiracetam Classification
  • 11. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 11 Conduction of nerve impulse
  • 12. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 12 Mechanism of action
  • 13. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 13 Phenytoin • First line drug for partial seizures. • Inhibits Na+ channels. • Prodrug- Fosphenytoin for IM/IV administration. High plasma protein binding. • Adverse effects: CNS sedation ( drowsiness, ataxia, confusion, insomnia, nystagmus), gum hyperplasia, hirsutism. Carbamazepine • First line drug for partial seizures. • Inhibits Na+ channels. • Adverse effects- CNS sedation, agranulocytosis and aplastic anaemia in elderly patients, leukopenia.
  • 14. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 14 Phenobarbital • Used for partial seizures, effective in neonates. • Second line drug in adults due to severe CNS sedation. • Allosteric modulator of GABA-A receptor (increase open time). • Adverse effects- CNS sedation but produces excitation in some patients. Skin rashes if allergic. Tolerance and dependence may be possible. Primidone • Used for partial seizures. • Allosteric modulator of GABA-A receptor (increase open time). • Not highly bound to plasma. • Adverse effects- CNS sedation.
  • 15. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 15 Benzodiazepines • Eg- Diazepam, Clonazepam. • Used to treat status epilepticus. • Allosteric modulators of GABA-A receptor- increase frequency. • Adverse effects- CNS sedation, paradoxical hyper excitability in children, tolerance and dependence. Valproate • Used for partial seizures, first line drug for generalized seizures. • Enhance GABA transmission, block Na+ channels, activates K+ channels. • Adverse effects- CNS depression, anorexia, nausea, vomiting, hair loss, weight gain, may cause birth defects.
  • 16. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 16 Ethosuximide • Used for absence seizures. • Blocks T-type Ca++ currents in thalamus. • Adverese effects- gastric distress, pain, nausea, vomiting. • Less CNS side effects than other anti-epileptic drugs, transient fatigue, dizziness, headache. Oxcarbamazepine • Approved for add-on therapy, monotherapy for partial seizures, that are refractory to other antiepileptic drugs. • Activity dependent blockade of Na+ channels, also open K+ channels. • Similar to carbamazepine, it causes CNS sedation, but may be less toxic.
  • 17. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 17 Gabapentin • Add-on therapy for partial seizures. • Also effective as monotherapy. • Interfere with GABA uptake. • Adverse effects- less CNS sedative than other classic anti-epileptic drugs. Lamotrigine • Add-on therapy and monotherapy for refractive partial seizures. • Effective against generalized seizures. • Inhibition of Na+ channels, inhibition of glutamate release, may inhibit Ca++ channels. • Less CNS sedative than other anti-epileptic drugs, dermatitis.
  • 18. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 18 Tiagabine • Add- on therapy for partial seizures. • Interferes with GABA reuptake. • CNS sedative • Minimal drug interaction. Zonisamide • Add- on therapy for partial and generalized seizures. • Blocks Na+ channels and T- type Ca++ channels. • Causes CNS sedation.
  • 19. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 19 Felbamate • Third-line drug for refractory partial seizures. • Frequency dependent- inhibition of Na+ channels, modulation of NMDA receptors. • Aplastic anaemia and severe hepatits reduces its use. Levetiracitam • Add- on therapy for partial seizures. • Binds to synaptical vessicle protein SV2A, may regulate neurotransmitter release. • Causes CNS ddepression.
  • 20. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 20 • Good absorption from gut, with a bioavailability of 80- 100%. • They show minimal plasma protein binding( except phenytoin, valproic acid). • Half life is usually 12- 24 hours and it increases upto 60 hours when plasma concentration of drug increases. • Metabolised in liver by non-CYP450 isoenzymes. • Enzyme inducers- Phenytoin, Phenobarbital. • Enzyme inhibitors- Valproate, Topiramate. • Primarily cleared renally. Pharmacokinetic profile
  • 21. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 21 • Used to treat partial, generalized and mixed seizures. • Used to treat Status epilepticus • Used as prophylaxis in case of tumours in brain. • Manic depressive illness and acute mania • Phenytoin is a group 1B anti-arrhythmic agent. • Several drugs, especially carbamazepine and lamotrigine, are useful for bipolar disorder. • Many drugs are useful in migraine, e.g., phenytoin, gabapentin, topiramate. Uses of Antiepileptic Drugs
  • 22. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 22 • Hypersensitivity reactions like rashes, photosensitivity, hepatitis • Vomiting, diarrhoea, weight loss, tremors • At high plasma levels- ataxia, vertigo, nystagmus, drowsiness • Gum hypertrophy • Aplastic anaemia • Foetal hydantoin syndrome • Osteoporosis • Teratogenesis • Neuropathy, coma • Epigastric pain, hypotension, arrythmias Adverse effects
  • 23. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 23 Contraindications • Cardiac patients • Pregnant women • Patients with livers disorder • People with lung infections etc Latest discovery • Levitiracitam • Brivaracetam • Cannabidiol • Stiripentol
  • 24. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 24 1. Padmaja Udaykumar. Pharmacology for Dental and Allied Health Sciences. 2017; 4th edition. 2. Tripathi, K. D. Essentials of Medical Pharmacology. 2013. JP Medical Ltd. 3. Christopher Melinosky. Epilepsy drugs used to treat seizures. WebMD. 2020. 4. Marketa Mavanova. Pharmacokinetic characteristics of antiepileptic drugs. NCBI. 2016; 6(1): 8-20. References
  • 25. RIPER AUTONOMOUS NAAC & NBA (UG) SIRO- DSIR Raghavendra Institute of Pharmaceutical Education and Research - Autonomous K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 25 THANK YOU